Optic neuritis anti-myelin basic protein synthetic peptide specificity

Journal of the Neurological Sciences

Volumn 109, Issue 1, 1992, Pages 88-95

  Warren, Kenneth G ^a   Catz, Ingrid ^a   Shutt, Kenneth ^a  

^a Multiple Sclerosis Patient Care and Research Clinic Department of Medicine Neurology) Department of Ophthalmology ^*  (Canada)

Author keywords

anti MBP; Optic neuritis; Synthetic peptides

Indexed keywords

MYELIN BASIC PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; HUMAN; OPTIC NERVE DISEASE; PRIORITY JOURNAL;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CEREBROSPINAL FLUID PROTEINS; CONVALESCENCE; EPITOPES; HUMAN; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; OPTIC NEURITIS; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T;

EID: 0026522227     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(92)90099-7     Document Type: Article

References (41)

1. An improved radioimmunoassay for myelin basic protein-like immunoreactive material in cerebrospinal fluid
2. Characterization of myelin basic protein catabolism products in the cerebrospinal fluid from multiple sclerosis, stroke and head injury patients
3. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS
4. Immunoblot detection of oligoclonal anti myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis
5. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species
6. Serum and cerebrospinal fluid antibodies against myelin basic protein and their IgG subclass distribution in multiple sclerosis
7. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases
8. Preparation and properties of monoclonal antibodies to myelin basic protein and its peptides
9. New monoclonal antibodies relative with defined epitopes in human myelin basic protein
10. Measurement of immunoreactive myelin basic protein peptide (45–89) in cerebrospinal fluid
11. Discussion of retro-ocular neuritis
12. Sites in myelin basic protein that react with monoclonal antibodies
13. Monoclonal antibodies reactive with myelin basic protein
14. Clinical and magnetic resonance imaging in optic neuritis
15. Cell-mediated immunity to myelin-associated glycoprotein; protolipid protein and myelin basic protein in multiple sclerosis
16. Immunoglobulins and measles antibodies in optic neuritis
17. Principles of albumin and IgG synthesis in neurological disorders. II. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis
18. Persistent anti-myelin basic protein IgG antibody response in multiple sclerosis cerebrospinal fluid
19. Preferential recognition of peptide 70–89 by anti-MBP antibody-producing cells in cerebrospinal fluid of multiple sclerosis patients
20. Antibodies to myelin-associated glygoprotein (MAG) in cerebrospinal fluid of multiple sclerosis patients
21. On cases of retro-ocular neuritis
22. Anti-myelin basic protein and anti-myelin antibody-producing cells in multiple sclerosis
23. Antibody to myelin basic protein in patients with multiple sclerosis and subacute sclerosing panencephalitis
24. Troubles Oculaires de la sclérose en plaques
25. Cerebrospinal fluid findings in patients with multiple sclerosis and optic neuritis
26. Optic neuritis: studies on the cerebrospinal fluid in relation to clinical course in 61 patients
27. Cerebrospinal fluid in 25 cases of optic neuritis
28. Problems of experimental trials of therapy in multiple sclerosis
29. T and B cell responses to myelin-oligodendiocyte glycoprotein in multiple sclerosis
30. Autoreactive T and B cells reproducing to myelin proteolipid protein in multiple sclerosis and controls
31. On cerebrospinal fluid immunoglobulin G (IgG) quotients in multiple sclerosis and other diseases
32. Discussion on retro-ocular neuritis
33. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of intrathecal production of autoantibodies
34. Diagnostic value of cerebro-spinal fluid and anti-myelin basic protein in patients with multiple sclerosis
35. A correlation between cerebro-spinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients
36. Cerebrospinal fluid antibodies to myelin basic protein in acute idiopathic optic neuritis
37. Neutralization of anti-myelin basic protein by cerebrospinal fluid of multiple sclerosis patients in clinical remission
38. Cerebrospinal fluid autoantibodies to myelin basic protein in multiple sclerosis patients. Detection during first exacerbations and kinetics of acute relapse and subsequent convalescent phases
39. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients
40. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebral fluid IgG of multiple sclerosis patients
41. Human myelin basic protein peptide 69–89: immunochemical features and use in immunoassays of cerebrospinal fluid